Discontinued — last reported Q4 '25
NXP Semiconductors Interest Paid decreased by 29.5% to $79.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 92.7%, from $41.00M to $79.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -3.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.00M | $56.00M | $140.00M | $45.00M | $133.00M | $39.00M | $106.00M | $54.00M | $86.00M | $38.00M | $83.00M | $38.00M | $86.00M | $27.00M | $92.00M | $41.00M | $109.00M | $44.00M | $112.00M | $79.00M |
| QoQ Change | — | -46.2% | +150.0% | -67.9% | +195.6% | -70.7% | +171.8% | -49.1% | +59.3% | -55.8% | +118.4% | -54.2% | +126.3% | -68.6% | +240.7% | -55.4% | +165.9% | -59.6% | +154.5% | -29.5% |
| YoY Change | — | — | — | — | +27.9% | -30.4% | -24.3% | +20.0% | -35.3% | -2.6% | -21.7% | -29.6% | +0.0% | -28.9% | +10.8% | +7.9% | +26.7% | +63.0% | +21.7% | +92.7% |